Relationship of -Blocker Dose with Outcomes in Ambulatory Heart Failure Patients with Systolic Dysfunction: Results from the HF-ACTION Trial

OBJECTIVES: To examine the association between baseline beta-blocker (BB) dose and outcomes in the HF-ACTION trial. BACKGROUND: BBs reduce morbidity and mortality in chronic heart failure (HF) patients with reduced ejection fraction, but it is unclear whether titrating to higher BB doses improves ou...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fiuzat, Mona, Wojdyla, Daniel, Kitzman, Dalane, Fleg, Jerome, Keteyian, Steven J., Kraus, William E., Piña, Ileana L., Whellan, David, O’Connor, Christopher M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396733/
https://ncbi.nlm.nih.gov/pubmed/22560018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.03.023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky